Mylan Pharmaceuticals Inc. et al. vs. Genentech, Inc. et al.
Explore the PTAB proceeding IPR2016-00710 filed by Mylan Pharmaceuticals Inc. et al. on 2016-03-03. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-00710
Filing Date
2016-03-03
Accorded Filing Date
2016-03-03
Institution Decision Date
2016-09-08
Last Modified Date
β
Proceeding Type
IPR
Termination Date
2017-05-10
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
Nimrod, Raymondet alPatent Owner / Respondent
Genentech, Inc. et al.
Represented By
Cavanaugh, Davidet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.
Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.
Genzyme Corporation et al. v. GENENTECH, INC. et al.
GENZYME CORPORATION et al. v. Genentech Inc. et al.
Sanofi-Aventis U.S. LLC et al. v. Genentech, Inc. et al.
Genentech, Inc. v. Immunex Rhode Island Corp.
Genentech, Inc. v. Samsung Bioepis Co., Ltd.
Eli Lilly and Company v. Genentech, Inc.